Ainos, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AIMD Nasdaq 2836 www.ainos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ainos, Inc.

VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability - Apr 17th, 2026 6:00 am
Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments - Apr 8th, 2026 6:00 am
VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment Momentum - Apr 1st, 2026 7:00 am
Ainos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026 - Mar 30th, 2026 7:00 am
RedChip AI Investor Conference Replays Now Available Featuring Public Companies Across the Artificial Intelligence Value Chain - Mar 26th, 2026 7:00 am
The Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor Environments - Mar 19th, 2026 6:00 am
Water Tower Research Highlights Ainos' Scaling Momentum Across Semiconductor Value Chain - Mar 12th, 2026 6:30 am
Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026 - Mar 9th, 2026 6:30 am
RedChip Showcases Public Companies Across the Artificial Intelligence Value Chain at March 19 Virtual Investor Conference - Mar 9th, 2026 5:30 am
Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue Opportunity - Mar 2nd, 2026 6:30 am
Ainos Activates Industrial-Scale Deployment Roadmap of Up to 20,000 Units, Advancing AI Infrastructure Integration in Semiconductor Production Environments - Feb 23rd, 2026 6:30 am
Ainos Reports Statistically Significant Interim Efficacy Results from VELDONA Clinical Trial in Feline Chronic Gingivostomatitis (FCGS) - Feb 17th, 2026 6:00 am
Ainos initiates live AI Nose deployments within semi manufacturing - Feb 10th, 2026 6:50 am
Ainos Initiates Live AI Nose Deployments within Semiconductor Manufacturing Environments - Feb 9th, 2026 6:00 am
Water Tower Research Highlights Mirle Partnership Fueling Ainos' Robotics Scale-Up and SmellTech Expansion - Feb 5th, 2026 6:00 am
Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value Creation - Feb 4th, 2026 6:00 am
Ainos and Mirle Automation Partner to Bring Scent Intelligence to Robots and Quadruped Robots - Feb 2nd, 2026 6:00 am
Ainos to Participate in Fireside Chat with Water Tower Research on January 26, 2026 - Jan 20th, 2026 7:00 am
Water Tower Research Highlights Ainos SmellTech's Rising Commercial Momentum in Scalable AI Infrastructure Platform Shift - Jan 12th, 2026 6:30 am
Ainos Announces Distribution Partnership with Trusval Technology to Expand AI Nose into Semiconductor Front-End Manufacturing - Jan 7th, 2026 6:30 am